SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-18-172196
Filing Date
2018-05-23
Accepted
2018-05-23 17:24:41
Documents
65
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 20-F/A d522997d20fa.htm 20-F/A 26188
  Complete submission text file 0001193125-18-172196.txt   8951966

Data Files

Seq Description Document Type Size
2 XBRL INSTANCE DOCUMENT eryp-20171231.xml EX-101.INS 2961086
3 XBRL TAXONOMY EXTENSION SCHEMA eryp-20171231.xsd EX-101.SCH 105255
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eryp-20171231_cal.xml EX-101.CAL 84598
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eryp-20171231_def.xml EX-101.DEF 445178
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE eryp-20171231_lab.xml EX-101.LAB 648979
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eryp-20171231_pre.xml EX-101.PRE 512067
Mailing Address 60 AVENUE ROCKEFELLER LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: 20-F/A | Act: 34 | File No.: 001-38281 | Film No.: 18855888
SIC: 2836 Biological Products, (No Diagnostic Substances)